Quest to Use CollabRx's Genetic Variant Annotation Services in NGS Testing | GenomeWeb

NEW YORK (GenomeWeb) – Data analytics firm CollabRx has inked a non-exclusive deal with Quest Diagnostics to provide the company with its medical annotation services.

Under the agreement, Quest will have access to medical content services from CollabRx, such as scientific literature, medical guidelines, and published therapeutic protocols. The services, marketed as Genetic Variant Annotation, were developed by CollabRx but customized by Quest.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.